DRD1 and Parkinson disease: In the rat 6-hydroxydopamine (6-OHDA) model of PD, GRK6 expression is reduced (an effect which persists even after administration of l-DOPA) (Ahmed et al. 2008), suggesting a possible involvement in D1R sensitization.